Further Discussion of Brightline-1 Trial (Brigimadlin)
New analysis highlights brigimadlin’s potential in DDLPS, despite BRIGHTLINE-1 not meeting its primary endpoint.
New analysis highlights brigimadlin’s potential in DDLPS, despite BRIGHTLINE-1 not meeting its primary endpoint.